Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation (Q36835147)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 June 2008

Language	Label	Description	Also known as
English	Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation	scientific article published on 6 June 2008

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation (English)

1 reference

Europe PubMed Central

16 August 2017

Lisbeth A. Welniak

4

object named as

Lisbeth A Welniak

0 references

William J. Murphy

5

object named as

William J Murphy

0 references

author name string

Kai Sun

1

1 reference

Europe PubMed Central

16 August 2017

Minghui Li

2

1 reference

Europe PubMed Central

16 August 2017

Thomas J Sayers

3

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

6 June 2008

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

112

1 reference

Europe PubMed Central

16 August 2017

4

1 reference

Europe PubMed Central

16 August 2017

1522-1529

1 reference

Europe PubMed Central

16 August 2017

CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Novel strategies for the treatment and diagnosis of graft-versus-host-disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Bortezomib as an antitumor agent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Pathophysiology of graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Graft-versus-host disease in the 21st century: new perspectives on an old problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Shared biology of GVHD and GVT effects: potential methods of separation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Immunobiology of acute graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Cytolytic pathways in haematopoietic stem-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Cytokine dysregulation and acute graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

Establishment and characterization of BALB/c lymphoma lines with B cell properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

29 September 2017

NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

27 June 2018

Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

27 June 2018

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

5 September 2018

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515132

5 September 2018

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF receptor p55 controls early acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional assessment and specific depletion of alloreactive human T cells using flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel tumor necrosis factor-knockout mice that lack Peyer's patches

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease path

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18539902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-03-143461

1 reference

Europe PubMed Central

16 August 2017

release_wvjjynk5enbe3dpribz6iye5dy

1 reference

https://api.fatcat.wiki/v0/release/wvjjynk5enbe3dpribz6iye5dy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36835147&oldid=1836683958"